ArticlePloS one2019

Recombinant human PRG4 (rhPRG4) suppresses breast cancer cell invasion by inhibiting TGFβ-Hyaluronan-CD44 signalling pathway.

Anusi Sarkar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.